Hemcheck Sweden AB (publ) has received a first smaller order from Astemed, which is the company's distributor in the United Arab Emirates. The order concerns instruments and v-Test and is of minor economic value.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 SEK | +10.17% |
|
-1.52% | -45.38% |
13/05 | Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/02 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-45.38% | 36.28L | |
-9.74% | 1.15TCr | |
-9.80% | 763.88Cr | |
+27.84% | 549.37Cr | |
-15.47% | 385.56Cr | |
+8.47% | 260.73Cr | |
-63.81% | 242.41Cr | |
-9.24% | 227.09Cr | |
+21.21% | 209.98Cr | |
-9.38% | 176.43Cr |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed